搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
3 天
on MSN
VIPRE Security Group says its new endpoint protection tools can stamp out even the latest ...
The latest VIPRE Endpoint EDR+MDR package empowers businesses with continuous expert incident response and a robust security ...
9 天
Getting Endpoint Management Right For The Hybrid Workforce
Douglas Murray is the chief executive officer at Auvik.
TechCentral
6 天
Elevating endpoint security for small enterprises
To secure endpoints effectively, small businesses should consider several critical components: ...
35 分钟
Kaseya VSA review
Kaseya VSA offers several monitoring and patch management functions, making it a complete RMM platform. You get the benefits ...
5 天
Malware attacks on endpoint management platform HCL BigFix possible
Attackers can exploit several vulnerabilities in HCL BigFix and compromise systems. Security updates provide a remedy.
1 天
Merck's Cell Tumor Experimental Drug Pimicotinib Met Primary Endpoint in Late-Stage Study
Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...
8 小时
Organogenesis (ORGO) Q3 2024 Earnings Call Transcript
ORGO earnings call for the period ending September 30, 2024. Organogenesis ( ORGO -1.43%) Q3 2024 Earnings Call Nov 12, 2024, ...
MassDevice
1 天
LivaNova nerve stim for sleep apnea meets primary study endpoints
LivaNova (Nasdaq:LIVN) today announced that its OSPREY trial of nerve stimulation for treating sleep apnea met its primary ...
15 小时
Syndax: Fall On NPM1m AML Data Of Revumenib Creates Buy Opportunity
Syndax Pharmaceuticals advances Revumenib for relapsed AML with FDA decision pending. See why SNDX stock is a key player in ...
Seeking Alpha
1 天
AbbVie Stock: Keep Calm And Buy The Dip
Dividend yield and robust drug pipeline are bullish going forward. AbbVie (NYSE:ABBV) shares are plummeting as the company's ...
in.investing.com on MSN
1 天
AbbVie shares slip after schizophrenia drug trial misses primary endpoint
Investing.com - AbbVie (NYSE:ABBV) has announced that its two phase 2 trials of a treatment for adults with schizophrenia ...
18 小时
AbbVie's Schizophrenia Failure Disappoints But Analysts Show Confidence In Immunology Portfolio
AbbVie stock drops after emraclidine fails Phase 2 trials for schizophrenia, raising questions about its neuroscience ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果
反馈